Phase 1 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older.
- People who have locally advanced cancer of the esophagus (the tube connecting the throat to the stomach).
- People who have a confirmed esophageal cancer tumor larger than 2 cm that has not yet been treated, and who are planned to receive both medication-based treatment and radiation therapy together as their main treatment.
- People who are able to sign a written consent form agreeing to take part, following the institution's guidelines.
- Women who could become pregnant must have a negative pregnancy test (blood or urine) within one week before the investigational scan takes place.
- Women who could become pregnant must agree to use an approved form of birth control before joining the trial and throughout their participation. Approved methods include hormonal contraception (such as pills, injections, implants, patches, or vaginal rings), an intrauterine device (IUD), tubal ligation, hysterectomy, a partner's vasectomy, implantable or injectable contraceptives, or condoms used with spermicide. Completely avoiding sexual activity for the full duration of the trial is also acceptable. Methods such as the rhythm method or withdrawal are not considered acceptable.
Who may not be able to join:
- People who weigh 400 pounds (approximately 181 kg) or more, or whose body size or physical condition would prevent the required scans from being completed.
- Women who are pregnant or currently breastfeeding, because the investigational scan agent may carry risks to a developing baby or a nursing infant.
- People who have had an allergic reaction to intravenous (IV) contrast dye in the past.
- People whose kidney function test result (called eGFR) is below 40 within the month before receiving the investigational scan agent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Steven Lin, MD, M.D. Anderson Cancer Center
Phone: (713) 563-8490
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.